{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:28:26Z","timestamp":1790994506807,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 HD052163"],"award-info":[{"award-number":["K12 HD052163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10549-015-3511-3","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T11:55:19Z","timestamp":1437738919000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer"],"prefix":"10.1007","volume":"153","author":[{"given":"A. Jo","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Duralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tsung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ning","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Melisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela N.","family":"Munster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch P.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,25]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20073","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin. doi:\n                    10.3322\/caac.20073","journal-title":"CA Cancer J Clin"},{"key":"3511_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-0-387-75115-3_10","volume":"151","author":"LA Emens","year":"2009","unstructured":"Emens LA, Davidson NE (2009) Postoperative endocrine therapy for invasive breast cancer. Cancer Treat Res 151:139\u2013161. doi:\n                    10.1007\/978-0-387-75115-3_10","journal-title":"Cancer Treat Res"},{"issue":"2","key":"3511_CR3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","volume":"7","author":"RW Carlson","year":"2009","unstructured":"Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7(2):122\u2013192","journal-title":"J Natl Compr Canc Netw"},{"key":"3511_CR4","doi-asserted-by":"crossref","unstructured":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005). Lancet 365 (9472):1687\u20131717","DOI":"10.1016\/S0140-6736(05)66544-0"},{"issue":"22","key":"3511_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97(22):1652\u20131662. doi:\n                    10.1093\/jnci\/dji372","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3511_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","volume":"28","author":"B Fisher","year":"2001","unstructured":"Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28(4):400\u2013418","journal-title":"Semin Oncol"},{"issue":"7","key":"3511_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","volume":"24","author":"JA Petrek","year":"2006","unstructured":"Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P (2006) Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24(7):1045\u20131051","journal-title":"J Clin Oncol"},{"issue":"8","key":"3511_CR8","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N (1999) Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17(8):2365\u20132370","journal-title":"J Clin Oncol"},{"issue":"5","key":"3511_CR9","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718\u20131729","journal-title":"J Clin Oncol"},{"issue":"2","key":"3511_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/01.coc.0000251398.57630.4f","volume":"30","author":"YL Tham","year":"2007","unstructured":"Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R (2007) The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 30(2):126\u2013132","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"3511_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1200\/JCO.2008.20.2119","volume":"28","author":"SS Lo","year":"2010","unstructured":"Lo SS, Mumby PB, Norton J, Rychlik K, Smerage J, Kash J, Chew HK, Gaynor ER, Hayes DF, Epstein A, Albain KS (2010) Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol 28(10):1671\u20131676. doi:\n                    10.1200\/JCO.2008.20.2119","journal-title":"J Clin Oncol"},{"issue":"3","key":"3511_CR12","first-page":"157","volume":"51","author":"T Rowe","year":"2006","unstructured":"Rowe T (2006) Fertility and a woman\u2019s age. J Reprod Med 51(3):157\u2013163","journal-title":"J Reprod Med"},{"issue":"2","key":"3511_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","volume":"8","author":"ER te Velde","year":"2002","unstructured":"te Velde ER, Pearson PL (2002) The variability of female reproductive ageing. Hum Reprod Update 8(2):141\u2013154","journal-title":"Hum Reprod Update"},{"issue":"Suppl 2","key":"3511_CR14","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1016\/j.breast.2007.07.029","volume":"16","author":"AH Partridge","year":"2007","unstructured":"Partridge AH, Ruddy KJ (2007) Fertility and adjuvant treatment in young women with breast cancer. Breast 16(Suppl 2):S175\u2013S181. doi:\n                    10.1016\/j.breast.2007.07.029","journal-title":"Breast"},{"issue":"2","key":"3511_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-008-9937-0","volume":"113","author":"SM Swain","year":"2009","unstructured":"Swain SM, Land SR, Ritter MW, Costantino JP, Cecchini RS, Mamounas EP, Wolmark N, Ganz PA (2009) Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 113(2):315\u2013320. doi:\n                    10.1007\/s10549-008-9937-0","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3511_CR16","doi-asserted-by":"publisher","first-page":"e66616","DOI":"10.1371\/journal.pone.0066616","volume":"8","author":"M Berliere","year":"2013","unstructured":"Berliere M, Duhoux FP, Dalenc F, Baurain JF, Dellevigne L, Galant C, Van Maanen A, Piette P, Machiels JP (2013) Tamoxifen and ovarian function. PloS One 8(6):e66616. doi:\n                    10.1371\/journal.pone.0066616","journal-title":"PloS One"},{"issue":"8","key":"3511_CR17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1990.8.8.1310","volume":"8","author":"F Boccardo","year":"1990","unstructured":"Boccardo F, Rubagotti A, Bruzzi P, Cappellini M, Isola G, Nenci I, Piffanelli A, Scanni A, Sismondi P, Santi L et al (1990) Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group. J Clin Oncol 8(8):1310\u20131320","journal-title":"J Clin Oncol"},{"issue":"6\u20137","key":"3511_CR18","first-page":"779","volume":"64","author":"A Manni","year":"1980","unstructured":"Manni A, Pearson OH (1980) Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64(6\u20137):779\u2013785","journal-title":"Cancer Treat Rep"},{"issue":"20","key":"3511_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC (1991) Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 83(20):1488\u20131491","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3511_CR20","first-page":"624","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC (1987) Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res 47(2):624\u2013630","journal-title":"Cancer Res"},{"issue":"2","key":"3511_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1172\/JCI109475","volume":"64","author":"BM Sherman","year":"1979","unstructured":"Sherman BM, Chapler FK, Crickard K, Wycoff D (1979) Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Investig 64(2):398\u2013404. doi:\n                    10.1172\/JCI109475","journal-title":"J Clin Investig"},{"issue":"3","key":"3511_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1530\/acta.0.1210417","volume":"121","author":"ML Swahn","year":"1989","unstructured":"Swahn ML, Bygdeman M, Matlin SA, Wu ZY (1989) The effect of tamoxifen on the function and lifespan of the corpus luteum and on subsequent ovarian function. Acta Endocrinol 121(3):417\u2013425","journal-title":"Acta Endocrinol"},{"issue":"9","key":"3511_CR23","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1200\/JCO.2005.03.0783","volume":"24","author":"M Colleoni","year":"2006","unstructured":"International Breast Cancer Study G, Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: international Breast Cancer Study Group Trial 13\u201393. J Clin Oncol 24(9):1332\u20131341. doi:\n                    10.1200\/JCO.2005.03.0783","journal-title":"J Clin Oncol"},{"issue":"31","key":"3511_CR24","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1200\/JCO.2012.47.7893","volume":"31","author":"A Valentini","year":"2013","unstructured":"Valentini A, Finch A, Lubinski J, Byrski T, Ghadirian P, Kim-Sing C, Lynch HT, Ainsworth PJ, Neuhausen SL, Greenblatt E, Singer C, Sun P, Narod SA (2013) Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. J Clin Oncol 31(31):3914\u20133919. doi:\n                    10.1200\/JCO.2012.47.7893","journal-title":"J Clin Oncol"},{"issue":"36","key":"3511_CR25","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","volume":"24","author":"JM Walshe","year":"2006","unstructured":"Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24(36):5769\u20135779. doi:\n                    10.1200\/JCO.2006.07.2793","journal-title":"J Clin Oncol"},{"issue":"24","key":"3511_CR26","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1200\/JCO.2004.05.192","volume":"22","author":"SL Bober","year":"2004","unstructured":"Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM (2004) Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol 22(24):4951\u20134957. doi:\n                    10.1200\/JCO.2004.05.192","journal-title":"J Clin Oncol"},{"issue":"18","key":"3511_CR27","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","volume":"28","author":"ME Ropka","year":"2010","unstructured":"Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28(18):3090\u20133095. doi:\n                    10.1200\/JCO.2009.27.8077","journal-title":"J Clin Oncol"},{"issue":"9","key":"3511_CR28","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/cncr.27952","volume":"119","author":"WT Lin","year":"2013","unstructured":"Lin WT, Beattie M, Chen LM, Oktay K, Crawford SL, Gold EB, Cedars M, Rosen M (2013) Comparison of age at natural menopause in BRCA1\/2 mutation carriers with a non-clinic-based sample of women in northern California. Cancer 119(9):1652\u20131659. doi:\n                    10.1002\/cncr.27952","journal-title":"Cancer"},{"issue":"2","key":"3511_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","volume":"28","author":"K Oktay","year":"2010","unstructured":"Oktay K, Kim JY, Barad D, Babayev SN (2010) Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks. J Clin Oncol 28(2):240\u2013244. doi:\n                    10.1200\/JCO.2009.24.2057","journal-title":"J Clin Oncol"},{"issue":"10","key":"3511_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1200\/JCO.2013.53.5369","volume":"32","author":"K Oktay","year":"2014","unstructured":"Oktay K, Moy F, Titus S, Stobezki R, Turan V, Dickler M, Goswami S (2014) Age-related decline in DNA repair function explains diminished ovarian reserve, earlier menopause, and possible oocyte vulnerability to chemotherapy in women with BRCA mutations. J Clin Oncol 32(10):1093\u20131094. doi:\n                    10.1200\/JCO.2013.53.5369","journal-title":"J Clin Oncol"},{"issue":"2","key":"3511_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/aje\/126.2.319","volume":"126","author":"GA Colditz","year":"1987","unstructured":"Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B, Hennekens CH, Speizer FE (1987) Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 126(2):319\u2013325","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3511_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJMe1405746","volume":"371","author":"HS Rugo","year":"2014","unstructured":"Rugo HS (2014) Hormone therapy in premenopausal women with early-stage breast cancer. N Engl J Med 371(2):175\u2013176. doi:\n                    10.1056\/NEJMe1405746","journal-title":"N Engl J Med"},{"issue":"9869","key":"3511_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Muller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrutia G, Valentini M, Wang Y, Peto R, Adjuvant Tamoxifen: Longer Against Shorter Collaborative G (2013) Long-term effects of continuing adjuvant tamoxifen to 10\u00a0years versus stopping at 5\u00a0years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805\u2013816. doi:\n                    10.1016\/S0140-6736(12)61963-1","journal-title":"Lancet"},{"issue":"8","key":"3511_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1634\/theoncologist.2014-0016","volume":"19","author":"KF Trivers","year":"2014","unstructured":"Trivers KF, Fink AK, Partridge AH, Oktay K, Ginsburg ES, Li C, Pollack LA (2014) Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist 19(8):814\u2013822. doi:\n                    10.1634\/theoncologist.2014-0016","journal-title":"Oncologist"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3511-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3511-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:06:48Z","timestamp":1589720808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3511-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3511-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,25]]},"assertion":[{"value":"18 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standards"}},{"value":"Informed consent was obtained from all individuals participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}